Trial Details
RECRUITINGBasic Information
| Clinical ID | c152 |
|---|---|
| Identifier | NCT07083193 |
| Trial Title | A Study of AC-101 Tablets in Participants With Moderate to Severe Active Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Ulcerative Colitis |
| Interventions | DRUG: AC-101 |
Participant Information
| Sponsor | Accro Bioscience (Suzhou) Limited |
|---|---|
| City | Guangdong |
| Country/Region | China |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE1|PHASE2 |
Time Information
| Start Date | 2025-01-20 |
|---|---|
| Primary Completion Date | 2026-09-30 |
| Completion Date | 2027-04-30 |